Clinical Trial Update: A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing how the A118G SNP in the OPRM1 gene influences opioid sensitivity and abuse-related effects in humans. Results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Snippet

Sponsor: Johns Hopkins University | Conditions: Opioid Sensitivity, Individual Difference | Phase 2 | Status: COMPLETED | Results posted: 2021-10-05